Work

MA26.10 CNS Activity of Ramucirumab in Combination with Osimertinib in Patients with Advanced T790M-Positive EGFR-Mutant NSCLC

Year: 2018

Type: conference-abstract

Source: Journal of Thoracic Oncology

DOI: 10.1016/j.jtho.2018.08.545

Authors: L. Paz-Ares, D. Planchard, J.C. Yang, K. Lee, P. Garrido, K. Park, J. Kim, D.H. Lee, H. Mao, B. Chao, H. Yu

Institutions: Hospital Universitario 12 De Octubre, Institut Gustave Roussy, Fondation Gustave Roussy, National Taiwan University, Chungbuk National University Hospital, Hospital Universitario Ramón y Cajal, Samsung Medical Center, Sungkyunkwan University, Yonsei University Health System, Yonsei Cancer Hospital, Asan Medical Center, University of Ulsan, Eli Lilly (United States), Memorial Sloan Kettering Cancer Center

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2898425871

Cites:

Cited by: 3

Related to: 10